Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products

24 Nov 2007

1

Aurobindo Pharma Ltd has reported having received five product approvals from the US Food and Drug Administration since October 2007 for the US market. These approvals include two Paragraph IV products, Finasterice Tablets USP and Glyburide and Metformin Hydrochloride Tablets.

 The products approved are for:

  • Glyburide tablets USP in dosages of 1.25, 2.5 and 5mg
  • Torsemide tablets in dosages of 5, 10, 20 and 100mg
  • Finasteride tablets USP in 5 mg
  • Atenolol tablets USP in dosages of 25, 50 and 100mg
  • Glyburide and mefformin hydrochloride tablets in dosages of 1.25mg, 250mg, 2.5mg, 500 mg and 5mg, and 500mg respectively

Aurobindo Pharma says it now has a total of 59 ANDAs approved by the US FDA

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more